Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
Go back to Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 13.15 -0.2 (1.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.35 | 52 Week High | $19.40 | |||
| Open | $13.45 | 52 Week Low | $12.50 | |||
| Day High | $13.79 | P/E | N/A | |||
| Day Low | $13.15 | EPS | $0.00 | |||
| Volume | 190,572 | |||||
